By Doug Macron

Although diagnostics based on microRNAs obtained from tissue samples have begun to gain traction in the marketplace, many see even greater value in the possibility that the small, non-coding RNAs can be obtained from biofluids for such tests.

To help advance work in this area, the National Institutes of Health recently awarded nearly $500,000 in grant funding to three researchers exploring the use of blood-based miRNAs as cancer biomarkers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.